Guyema-Faber Disease

Guyema-Faber disease is a rare blood disorder characterized by a decrease in the number of red blood cells, white blood cells and platelets.

The disease was first described in 1888 by the French physician Georges Iam and in 1904 by the Danish physician Carl Faber.

The reasons for the development of Gayem-Faber disease are not fully understood. It is assumed that the main role is played by disruption of hematopoietic processes in the bone marrow.

The main symptoms of the disease: pallor of the skin and mucous membranes, weakness, shortness of breath, tachycardia, increased fatigue, bleeding.

Diagnosis is based on a general blood test, which detects a decrease in all blood elements.

Treatment consists of donated blood transfusions, corticosteroids and immunosuppressants. The prognosis with timely treatment is favorable.

Guyema-Faber disease is a rare genetic disease that causes metabolic disorders and visual defects. It was first described by the French physician Guyom in 1878 and the Danish physician Faber in 1907. Today, this disease remains rare, but important, as it requires complex treatment and medical care.

Gayemow-Fabercy disease, or ferinase deficiency, is an inherited disease that occurs due to genetic defects in the functioning of enzymes called ferinases. These enzymes are responsible